A detailed history of Auxier Asset Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Auxier Asset Management holds 669 shares of LLY stock, worth $608,341. This represents 0.1% of its overall portfolio holdings.

Number of Shares
669
Previous 700 4.43%
Holding current value
$608,341
Previous $544,000 11.21%
% of portfolio
0.1%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$724.87 - $909.04 $22,470 - $28,180
-31 Reduced 4.43%
669 $605,000
Q1 2024

May 08, 2024

SELL
$592.2 - $792.28 $6,514 - $8,715
-11 Reduced 1.55%
700 $544,000
Q4 2023

Feb 22, 2024

SELL
$525.19 - $619.13 $13,129 - $15,478
-25 Reduced 3.4%
711 $414,000
Q3 2023

Nov 21, 2023

BUY
$434.7 - $599.3 $4,347 - $5,993
10 Added 1.38%
736 $395,000
Q4 2021

Mar 01, 2022

BUY
$224.85 - $279.04 $163,241 - $202,583
726 New
726 $201,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Auxier Asset Management Portfolio

Follow Auxier Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Auxier Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Auxier Asset Management with notifications on news.